Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.Telix Pharmaceuticals Ltd is a biotechnology company. It is engaged in the development and commercialization of molecularly-targeted radiation therapy to address the clinical unmet needs in the management of prostate, renal and glioblastoma cancer.